Abstract
Herpes Viruses induce many disease entities in humans. Unfortunately, the drugs currently used in the clinical treatment of herpes virus infectious diseases all have substantial toxicity (1,2,3). Recently, several nucleoside analogs such as AraA, 5-alkyl dUrd and Acycloguanine were shown to be effective against herpes simplex virus type 1 infectious diseases without having much toxicity in humans (4–10) however, they all have their own limitation of use. For example, 5-alkyl-dUrd and acycloguanosine will not be active against herpes virus which cannot induce thier virus specific thymidine kinase (TK) (6,11) or herpes virus which could induce a virus specific TK but cannot recognize either compound as its substrate. AraA toxicity will be affected by the amount of adenosine deaminase in human cells. Therefore, it is important to develop more specific antiherpes virus agents for the treatment of herpes virus induced diseases, particularly in patients undergoing cancer chemotherapy or with immune deficiencies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Luby, J.P., Johnson, M.T. and Jones, S.R. Am. Rev. of Pharmacol. 14: 251, 1974.
Tilles, J.G., Ann. Rev. of Med. 25: 469, 1974.
Calabresi, P., Cardoso, S.S., Finch, S.C., Kligerman, M.M.,VonEssen, C.F., Chu, M.Y. and Welch, A.D. Cancer Res. 21: 550, 1961.
Gauri, K.K. Personal Communication.
Elion, G.B. Personal Communication.
Elion, G.B., Furman, P.A., Fyfe, J.A., Miranda, P.D., Beauchamp,L. and Schaeffer, H. J. Proc. Natl. Acad. Sci., 74: 5716, 1977.
Schaeffer, H.J., Beauchamp, L., deMiranda, P., Elion, G.B., Baner, P.J. and Collins, P. Nature, 272: 583, 1978.
Whitley, R.J. New Eng. J. Med., 294: 1193, 1976.
Whitley, R.J. New Eng. J. Med., 297: 289, 1977.
Prusoff, W.H. and Ward, D. Biochem. Pharmacol., 25; 1233, 1976.
Cheng, Yung-chi, Domin, B., Sharma, R. and Bobek, M. Anti-microbiol. Agents and Chemotherapy, 10: 119, 1976.
Klein, G., P. Clifford, E. Klein, R.T. Smith, J. Minowada, F.M.Kourilsky, and J.H. Burchenal. J. Nat. Cancer Institute 39: 1027, 1967.
de The. G., Editors: P.M. Biggs, G. de The and L.N. Payne (eds.), Oncogenesis and Herpes viruses. Int. Agency for Res. on Cancer, Lyon., Page 275, 1972.
Henle, W. and G. Henle. In: R. M. Butcher (ed.), Comparative Leukemia Research 1969, Karger, Basel., Page 706–713, 1970.
Schryver, A. de, S. Friberg, Jr., G. Klein, W. Henle, G. Hall,G. de The, P. Clifford, and H.C. Ho. Clin. Exp. Immunol., 5; 443, 1969.
Rawls, W.E., W.A. Tompkins and J.L. Melnick. The Amer. J.Epidemiol., 89: 547, 1969.
Aurelian, L. Cancer Res, 34:1126,1974
Aurelian, L.J., D. Strandberg, L.V. Melendez and L.A. Johnson. Science, 174: 704, 1971.
International Symposium on Human Tumors Associated with Herpes Virus,Cancer Res.34:1083,1974
Rapp, F. and Westmoreland, D. Biochim. Biophys. Acta 458: 167, 1976.
Allen, D.W. and Cole, P. New Eng. J. of Med., 286: 70, 1972.
Klein, G. In: “The Herpes Viruses”p. 521, A. Kaplan (ed.),Academic Press, Inc., London and N.Y., 1973.
Trumper, P.A., Epstein, M.A., Giovandla, B.C. and Finerty, S.Int. J. Cancer, 20: 655, 1977.
Cheng, Yung-chi and Ostrander, J. J. Biol. Chem. 251: 2605, 1976.
Hoffman, P.H. and Cheng, Yung-chi. J. Biol. Chem., 253: 3557, 1978.
Cheng, Yung-chi, Kung, M.P. and Hoffmann, P.J. Oncogenesis and Herpes Virus III 899, 1979. International Agency for Research on Cancer.
Roizman, B. and Furlong, D. Comprehansive Virology 3 229,1974. Ed. H. Fraenkel-Conrat and R.R. Wager, Plenum Press.
Miller, R.L., R. Glaser, and F. Rapp. Virol 76:492,1977
Goodman, S.R., Pryna, W., Benz, W.C. J. Biol. Chem. 253: 8617, 1978.
Huang, E.S. J. Virol., 16: 298, 1975.
Mar, E.C., Hung, Y.S. and Huang, E.S. J. Virol., 26: 249, 1978.
Keir, H.M. and Gold, E., Biochim. Biophys. Acta 72: 263, 1963.
Keir, H.M., Hay, J., Morrison, J.M. and Subak-Sharpe, H. Nature, 210; 369, 1966.
Morrison, J.M. and Keir, H.M. Biochem. J., 103: 70, 1967.
Morrison, J.M. and Keir, H.M. J. Gen. Virol., 3 337, 1968.
Keir, H.M. “Molecular Biology of Viruses”, 18: 67, 1968, Cambridge Univ. Press. Cambridge.
Weissbach, A., Hong, S.-C. L., Aucker, J. and Muller, R. J. Biol. Chem., 248: 6270, 1973.
Purifoy, D.J.M., and Powell, K.L. J. Virol., 24 618, 1977.
Leinbach, S.S., Reno, J.M., Lee, L.F., Isball, A.F. and Boezi, J.A. Biochem., 15: 427, 1976.
Cheng, Yung-chi, Chen, J.Y., Hoffman, P.J. and Glaser, R.(submitted).
Cheng, Yung-chi, Goz, B. and Prusoff, W.H. Biochim Biophys. Acta, 390: 253, 1975.
Ogino, T., Shiman, R. and Rapp, F. Intervirology, 1 80, 1973.
Jamieson, A.T. and Subak-Sharpe, J.H., J. Gen. Virol., 24: 481, 1974.
Thonless, M.E. J. Gen. Virol., 17: 307, 1972.
Kit, S., Leung, W.-C., Jorgeson, G.N. and Dubbs, D.R. Int. J. Cancer 14: 598, 1974.
Kit, S. and Dubbs, D.R. Virology 26: 16, 1965.
Hackstat, T. and Mallavia, L.P. J.Virol., 25: 510, 1978.
Dobersen, M.T., Jerkofsky, M. and Greer, S. J. Virol., 20: 1232, 1977.
Ogino, T., Olsuka, T., and Takahashi, M. J. Virol., 21: 1232, 1977.
Cheng, Y.C., Tsou, T., Hackstat, T. and Mallavia, L.T. J.Virol. (In Press).
Chen, S.T., Estes, J.E., Huang, E.S. and Pagano, J.S. J. Virol., 26: 203, 1978.
Estes, J.E. and Huang, E.S. J. Virol. 241: 261, 1977.
Cheng, Y.-C., Hoffmann, P.J., etal., Adv. in Opthalmology, 34: (In press).
Ponce De Lyon, J., Zisenberg, R.J. and Chen, G.H. J. Gen.Virol. 36, 163–173 1977.
Langelier, Y., DeChamps, M. and Butten, G. J. Virol. 26: 547–553, 1978.
Cheng,Yüng-chi, Chadha, K.C. and Hughs, R. Inf. and Immunol., 16: 486, 1977.
Berk, A.J. and Clayton, D.A. J. Biol. Chem., 248: 2722, 1973.
Kit, S. and Leung, W.-C., Biochem, Genetics, 11: 231, 1974.
Lee, L.-S. and Cheung, Yung-chi., J. Biol. Chem., 251: 2600, 1976.
Lee, L.S. and Cheng, Yung-chi., Biochemistry, 15: 3686, 1976.
Cheng, Yung-chi, Biocim. Biophys. Acad., 452: 370, 1976.
Cheng, Yung-chi., Ann. Rev. N.Y. Acad. Sci. 284: 594, 1977.
Chen, J.Y. and Cheng, Yung-chi., The Pharmacologist 21 (1): 20, 1979.
Cheng, Yung-chi, Grill, S., Deutchman, G. (submitted).
Chen, M.S., and Ward, D.C. and Prusoff, W.H., J. Biol. Chem., 251: 4833, 1976.
Miller, R.L., Iltis, J.P. and Rapp, F., J. Virol., 23: 679, 1977.
Aswell, J.F., Allen, G.P., Jamieson, A.T., Campbell, D.E. and Gentry, G.A., Antimicrob. Agent and Chem., 12: 243, 1977.
Gibson, W. and Roizman, B., Proc. Natl. Acad. Sci. U.S.A., 68: 2818, 1971.
Cheng, Yung-chi. In: Proc. Antimetabolites in Biochemistry, Biology and Medicine. J. Skoda and P. Langen, ed. Pergamon Press, N.Y. and London, 117, 1969.
Glick, J.L. “Axemic Mammalian Cell Reactions”. Marcel Dekker Press, N.Y. and London, 117, 1969.
Mathias, A.P. and Fischer, G.A., Biochem. Pharmacol. 11: 69, 1962.
Meizel, S. and Kay, E.R.M. Biochim. Biophys. Acta, 103: 431, 1965.
Ledoux, L., Gerber, G.B., Charles, D., Remy, J. and Rey-De-fraighe, J. J. Experimentia, 23: 16, 1967.
Glick, J.T.Cancer Res 27:2338,1967.
Kung, M.-P, Ho, Y.-K., and Bardos, T.J. Cancer Res36: 4536, 1976
Pattenholz, V., La, H.V., Ho, Y-K. and Bardos, T.J.Cancer Res36:1445, 1976.
Hay, J., Brown, S.M., et.al,. J. Antimicrob. Chemother. 3 (Suppl. A): 63–70, 1977.
Hay, J. and Subak-Sharpe, J. J. Gen. Birol. 31: 105–108, 1976.
Ostrander, M. and Cheng, Yung-chi. Pharmacologist, 19: 151, 1977.
Ostrander, M. and Cheng, Yung-chi. 11th International Congress of Biochemistry, In Press.
Ostrander, M. Ph.D. Thesis.
Leinbach, S.S., Reno. J.M., Lee, L.F., Isbell, A.F. and Boezi,J.A.Biochem,15: 26,1976
McClure, W.R. and Jovin, T.M. J. Biol. Chem. 250: 4073, 1975.
Muller, W.E.G., Zahn, R. K., Bittlingmaiier, K. and Falke, D.,N.Y. Acad. Sci., 284: 34, 1977.
Reno, J. T., Lee, L.F. and Boegi J.Antimicro.Ag.,Chemother. 13: 188, 1978.
Cheng, Yung-chi and Prusoff, W.H. Biochem Pharmacol 22; 3099 1973
Allaudeen, H.S. and Berlin, J.R. Biochim Biophys.Acta 520, 490, 1978.
Allaudeen, H.S. and Berlin, J.R Proc. Natl. Acad. Sci. 75,. 4504, 1978.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Press, New York
About this chapter
Cite this chapter
Cheng, YC., Ostrander, M., Derse, D., Chen, JY. (1979). Development of Antiherpes Virus Agents on the Basis of Virus Induced Enzymes. In: Walker, R.T., De Clercq, E., Eckstein, F. (eds) Nucleoside Analogues. NATO Advanced Study Institutes Series, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9137-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9137-5_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9139-9
Online ISBN: 978-1-4615-9137-5
eBook Packages: Springer Book Archive